Literature DB >> 2899442

Mechanism of multidrug resistance.

G Bradley1, P F Juranka, V Ling.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2899442     DOI: 10.1016/0304-419x(88)90006-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


× No keyword cloud information.
  130 in total

1.  Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype.

Authors:  P A te Boekhorst; J van Kapel; M Schoester; P Sonneveld
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

2.  Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.

Authors:  A Redmond; E Law; U Gilvarry; M Clynes
Journal:  Cell Biol Toxicol       Date:  1990-07       Impact factor: 6.691

Review 3.  Treatment of multiple myeloma in elderly patients. New developments.

Authors:  G J Ossenkoppele
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 4.  Resistance to cytostatic drugs at the cellular level.

Authors:  C P Vendrik; J J Bergers; W H De Jong; P A Steerenberg
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  Dose dependence of the cytokinetic and cytotoxic effects of epirubicin in vitro.

Authors:  D Bartkowiak; J Hemmer; E Röttinger
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Malignant phenotype correlating with drug resistance in two human neuroblastoma cell lines.

Authors:  Y Wollman; I Shahar; M Goldstein; J Leibovici
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  The structure of P-glycoprotein and the secretion of lysosomal enzymes in multidrug-resistant cells.

Authors:  L Warren; A Malarska; J C Jardillier
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

8.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

9.  Reversal of daunorubicin resistance in P388/ADR cells by itraconazole.

Authors:  S Gupta; J Kim; S Gollapudi
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

10.  Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.

Authors:  Giulio Francia; Shan Man; Beverly Teicher; Luigi Grasso; Robert S Kerbel
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.